We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

USMCA’s biologics extension provision removed

Intellectual Property Magazine

USMCA’s biologics extension provision removed

The controversial provision that granted pharma companies biologicpatent extensions has reportedly been removed from a newly redesigned version of the US-Mexico-Canada-Agreement (USMCA).

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more